Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 24

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The Role of Dermal Matrices in Treating Inflammatory and Diabetic Wounds

Climov, Mihail, Bayer, Lauren R., Moscoso, Andrea V., Matsumine, Hajime, Orgill, Dennis P.·2016·Plastic & Reconstructive Surgery
DOI 10.1097/prs.0000000000002652
Open this paper in CoChat — free account

Abstract

Background: Dermal matrices are used to improve healing in both acute and chronic wounds including diabetic and lower extremity wounds, burns, trauma, and surgical reconstruction. The use of dermal matrices for the closure of inflammatory ulcerations is less frequent but growing. Currently available products include decellularized dermis and semisynthetic matrices. Methods: A review of the published literature was performed to identify reports that use acellular dermal matrices in diabetic and inflammatory wounds. Studies were evaluated for quality and outcomes, and a level of evidence was assigned according to the American Society of Plastic Surgeons’ Rating Levels of Evidence. Case studies from the authors’ experience are also presented. Results: Seventeen primary studies evaluating the use of dermal matrices in diabetic ulcers were identified with 2 based on level I data. There are no prospective clinical trial reports of their use in atypical or inflammatory wounds, but there are several case studies. Conclusions: Treatment of diabetic and inflammatory wounds may include both medical and surgical modalities. The use of dermal matrices can be a useful adjunct, but their optimal use will require future clinical studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/prs.0000000000002652

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 39

  1. Sen, 2009, Human skin wounds: a major and snowballing threat to public health and the economy., Wound Repair Regen, 17, 763, 10.1111/j.1524-475X.2009.00543.x · DOI · Paper page
  2. Gottrup, 2004, A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds., Am J Surg, 187, S38, 10.1016/S0002-9610(03)00303-9 · DOI · Paper page
  3. Martin, 2005, Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience., Int Wound J, 2, 161, 10.1111/j.1742-4801.2005.00099.x · DOI · Paper page
  4. Nyame, 2014, Clinical applications of skin substitutes., Surg Clin North Am, 94, 839, 10.1016/j.suc.2014.05.013 · DOI · Paper page
  5. Janis, 2011, The new reconstructive ladder: modifications to the traditional model., Plast Reconstr Surg, 127, 205S, 10.1097/PRS.0b013e318201271c · DOI
  6. Lazic, 2011, Bioengineered skin constructs and their use in wound healing., Plast Reconstr Surg, 127, 75S, 10.1097/PRS.0b013e3182009d9f · DOI
  7. Iorio, 2012, Wound healing in the upper and lower extremities: a systematic review on the use of acellular dermal matrices., Plast Reconstr Surg, 130, 232S, 10.1097/PRS.0b013e3182615703 · DOI
  8. Singh, 2005, Preventing foot ulcers in patients with diabetes., JAMA, 293, 217, 10.1001/jama.293.2.217 · DOI
  9. Sullivan, 2011, The level of evidence pyramid: indicating levels of evidence in plastic and reconstructive surgery articles., Plast Reconstr Surg, 128, 311, 10.1097/PRS.0b013e3182195826 · DOI
  10. Reyzelman, 2009, Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study., Int Wound J, 6, 196, 10.1111/j.1742-481X.2009.00585.x · DOI · Paper page
  11. Brigido, 2006, The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study., Int Wound J, 3, 181, 10.1111/j.1742-481X.2006.00209.x · DOI
  12. Williams, 2015, Use of a human acellular dermal wound matrix in patients with complex wounds and comorbidities., J Wound Care, 24, 261, 10.12968/jowc.2015.24.6.261 · DOI
  13. Karr, 2011, Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf)., Adv Skin Wound Care, 24, 119, 10.1097/01.ASW.0000395038.28398.88 · DOI
  14. Kavros, 2014, The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study., Adv Skin Wound Care, 27, 356, 10.1097/01.ASW.0000451891.87020.69 · DOI
  15. Hoffman, 2007, Inflammatory ulcers., Clin Dermatol, 25, 131, 10.1016/j.clindermatol.2006.09.010 · DOI
  16. Panuncialman, 2006, Basic approach to inflammatory ulcers., Dermatol Ther, 19, 365, 10.1111/j.1529-8019.2006.00097.x · DOI
  17. Reichrath, 2005, Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients., J Am Acad Dermatol, 53, 273, 10.1016/j.jaad.2004.10.006 · DOI
  18. Liaqat, 2014, Acute postoperative pyoderma gangrenosum case and review of literature identifying chest wall predominance and no recurrence following skin grafts., J Am Acad Dermatol, 71, e145, 10.1016/j.jaad.2014.05.022 · DOI
  19. Tolkachjov, 2015, Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014., J Am Acad Dermatol, 73, 615, 10.1016/j.jaad.2015.06.054 · DOI
  20. Minniti, 2016, Critical reviews: how we treat sickle cell patients with leg ulcers., Am J Hematol, 91, 22, 10.1002/ajh.24134 · DOI
  21. Rashid, 2012, Management of massive soft tissue defects: the use of INTEGRA® artificial skin after necrotizing soft tissue infection of the chest., J Thorac Dis, 4, 331
  22. Mazzone, 2013, Management of septic skin necroses., Eur J Pediatr Surg, 23, 349, 10.1055/s-0033-1352530 · DOI
  23. Muangman, 2006, Complex wound management utilizing an artificial dermal matrix., Ann Plast Surg, 57, 199, 10.1097/01.sap.0000218636.61803.d6 · DOI
  24. Akhtar, 2006, The use of Integra in necrotizing fasciitis., Burns, 32, 251, 10.1016/j.burns.2005.06.009 · DOI
  25. Gilmour, 2012, Use of Integra(R) Dermal Regeneration Template in excision and reconstruction of pre-tibial necrobiosis lipoidica: a case report., Br J Diabetes Vasc Dis, 12, 261, 10.1177/1474651412460876 · DOI
  26. Rosique, 2015, Curbing inflammation in skin wound healing: a review., Int J Inflam, 2015, 1
  27. Kirsner, 2015, Human acellular dermal wound matrix: evidence and experience., Int Wound J, 12, 646, 10.1111/iwj.12185 · DOI · Paper page
  28. Yannas, 2011, Template for skin regeneration., Plast Reconstr Surg, 127, 60S, 10.1097/PRS.0b013e318200a44d · DOI
  29. Li, 2004, Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells., Endothelium, 11, 199, 10.1080/10623320490512390 · DOI
  30. Hodde, 2005, An investigation of the long-term bioactivity of endogenous growth factor in OASIS Wound Matrix., J Wound Care, 14, 23, 10.12968/jowc.2005.14.1.26721 · DOI
  31. Brigido, 2004, Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: A pilot study., Orthopedics, 27, 145, 10.3928/0147-7447-20040102-14 · DOI · Paper page
  32. Winters, 2008, A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds., Adv Skin Wound Care, 21, 375, 10.1097/01.ASW.0000323532.98003.26 · DOI · Paper page
  33. Brigido, 2009, Use of an acellular flowable dermal replacement scaffold on lower extremity sinus tract wounds: a retrospective series., Foot Ankle Spec, 2, 67, 10.1177/1938640009333474 · DOI
  34. Silverstein, 2006, Dermal regeneration template in the surgical management of diabetic foot ulcers: a series of five cases., J Foot Ankle Surg, 45, 28, 10.1053/j.jfas.2005.10.005 · DOI
  35. Clerici, 2009, The use of a dermal substitute (integra) to preserve maximal foot length in a diabetic foot wound with bone and tendon exposure following urgent surgical debridement for an acute infection., Int J Low Extrem Wounds, 8, 209, 10.1177/1534734609350553 · DOI
  36. Clerici, 2010, The use of a dermal substitute to preserve maximal foot length in diabetic foot wounds with tendon and bone exposure following urgent surgical debridement for acute infection., Int Wound J, 7, 176, 10.1111/j.1742-481X.2010.00670.x · DOI
  37. Iorio, 2011, Functional limb salvage in the diabetic patient: the use of a collagen bilayer matrix and risk factors for amputation., Plast Reconstr Surg, 127, 260, 10.1097/PRS.0b013e3181f95c4b · DOI
  38. Fraccalvieri, 2012, Can the combined use of Integra, skin graft and negative pressure wound therapy be considered a valid therapeutic approach after partial tangential calcanectomy?, Int Wound J, 9, 214, 10.1111/j.1742-481X.2011.00878.x · DOI
  39. Yao, 2013, Ease of use, safety, and efficacy of integra bilayer wound matrix in the treatment of diabetic foot ulcers in an outpatient clinical setting: a prospective pilot study., J Am Podiatr Med Assoc, 103, 274, 10.7547/1030274 · DOI

Cited by

Metadata

Authors
Climov, M., Bayer, L. R., Moscoso, A. V., Matsumine, H., & Orgill, D. P.
Venue
Plastic & Reconstructive Surgery
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2016-09
Volume
138
Issue
3S
Pages
148S-157S
ISSN
0032-1052
DOI
10.1097/prs.0000000000002652
Cited by
24
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.